BUZZ-Australia's Imricor Medical Systems soars on US FDA clearance for MRI catheter
Reuters
Jan 12
BUZZ-Australia's Imricor Medical Systems soars on US FDA clearance for MRI catheter
** Shares of Australia's Imricor Medical Systems IMR.AX rise as much as 26% to A$1.99, their highest level since July 21, 2021
** Stock posts its biggest intraday pct gain in nearly three years
** Medical device developer says the U.S. Food and Drug Administration (FDA) has granted clearance to commercially market its Vision-MR Diagnostic Catheter
** Vision-MR Diagnostic Catheter enables electrophysiologists to use MRI for precise, clear visualisation of cardiac anatomy
** IMR rose 12.5% in 2025
(Reporting by Aamir Sheik Khalid in Bengaluru)
((Aamir.SheikKhalid@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.